InspireMD (NSPR) Asset Writedowns and Impairment (2015)

InspireMD (NSPR) reported Asset Writedowns and Impairment of $260000.0 for Q3 2015, down 17.72% quarter-over-quarter from $316000.0 in Q1 2015.

InspireMD (NSPR) Asset Writedowns and Impairment (2015) Analysis & Trends

InspireMD has reported Asset Writedowns and Impairment for 1 years, with the latest figure at $260000.0 in Q3 2015.

For the quarter ending Q3 2015, Asset Writedowns and Impairment changed N/A year-over-year to $260000.0; the trailing twelve-month figure through Dec 2015 stood at $576000.0 (changed N/A YoY), and the FY2015 full-year result was $576000.0, changed N/A from the prior year.
Asset Writedowns and Impairment for Q3 2015 stood at $260000.0, down from $316000.0 in the prior quarter.
The five-year high for Asset Writedowns and Impairment was $316000.0 in Q1 2015, with the low at $260000.0 in Q3 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn
10	InspireMD	45.74 Mn	-8.48 Mn	1.18 Mn

Download Data